Table 3.
Exclusion and inclusion criteria.
| Exclusion criteria | (1) With a history of pulmonary embolism, pulmonary fibrosis, chronic obstructive pulmonary disease, pleural effusion, active tuberculosis, bronchiectasis, and pneumonectomy |
| (2) Pregnant and lactating women | |
| (3) Showing exacerbation of symptoms requiring additional medications during screening period | |
| (4) Malignant tumour and blood disease | |
| (5) Participating in other clinical trials in the past three months | |
| (6) Use of oral corticosteroids in the previous four weeks | |
| (7) Experienced an infectious disease within four weeks | |
| (8) With heart, liver, kidney, or other organ diseases | |
|
| |
| Inclusion criteria | (1) 18 to 70 years old; any gender |
| (2) With mild-to-moderate asthma | |
| (3) ACT ≥ 20 score, FEV1% ≥ 60% | |
| (4) Having a history of recurrent asthma exacerbations in the past two years | |
| (5) Without upper and lower respiratory tract infections in the past four weeks | |
| (6) With Kidney and Qi deficiency based on TCM syndrome differentiation | |
| (7) Understanding of the research protocol and consent to participate | |